Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Osteosarcoma
is the most common primary bone tumor in humans, especially in childhood. However, the genetic etiology for its pathogenesis remains elusive. It is known that microRNAs (miRNAs) are involved in the development of tumor progression. Here we show that microRNA-9 (miR-9) is a potential oncogene upregulated in
osteosarcoma
cells. Knockdown of miR-9 in
osteosarcoma
resulted in suppressed colony formation and cell proliferation. Further study identified
GCIP
, a Grap2 and cyclin D interacting protein, as a direct target of miR- 9. In addition,
GCIP
overexpression activated retinoblastoma 1 (Rb) and suppressed E2F transcriptional target expression in
osteosarcoma
cells. Moreover,
GCIP
depletion reversed miR-9 knockdown induced colony formation and cell proliferation suppression. In sum, these results highlight the importance of miR-9 as an oncogene in regulating the proliferation of
osteosarcoma
by directly targeting
GCIP
and may provide new insights into the pathogenesis of
osteosarcoma
.
...
PMID:miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor. 2610 95